Bristol Myers to Acquire Karuna, a Neuroscience Drugmaker, for $14 Billion

Bristol Myers Squibb, the global pharmaceutical giant, said on Friday that it would acquire Karuna Therapeutics, which makes drugs to ...

Read more



source https://alternativenewsreport.net/bristol-myers-to-acquire-karuna-a-neuroscience-drugmaker-for-14-billion/

Post a Comment

Please Select Embedded Mode To Show The Comment System.*

Previous Post Next Post